IL4 and colitis: All in all, Dioscin has a protective effect on DSS‐triggered colitis and LPS/IL‐4‐triggered RAW264.7 cell injury, which is achieved by restraining the inflammatory response and colonic macrophage infiltration, especially by regulating the polarization of macrophages.